Cargando…

2545. Impact of Early Dose Adjustment of Beta-Lactams in Patient with Septic Shock

BACKGROUND: Effective antimicrobial dosing is crucial for survival in patient with septic shock. However, attaining therapeutic antimicrobial serum concentration is often problematic due to pathophysiological changes associated with critical illness. Antimicrobial concentrations can be decreased due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tawwater, John C, Adams, David T, Kaur, Satwinder S, Ibragimova, Nayle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678611/ http://dx.doi.org/10.1093/ofid/ofad500.2162

Ejemplares similares

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

2545. Needs Assessment for a Presentation Skills Curriculum in an Infectious Diseases Fellowship Program
por: Bares, Sara H, et al.
Publicado: (2019)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

1200. Evaluation of Pharmacist-Driven Azithromycin Dose Optimization Protocol for Respiratory Tract Infections as an Antimicrobial Stewardship Initiative
por: Kaur, Satwinder S, et al.
Publicado: (2023)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
por: Taccone, Fabio Silvio, et al.
Publicado: (2010)

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases
por: Farshid, G, et al.
Publicado: (2011)

PB2545: HAEMATOLOGICAL INDICES IN DIFFERENTIAL DIAGNOSIS OF MICROCYTIC ANEMIAS, A REGIONAL STUDY
por: Myrtaj, Rialda, et al.
Publicado: (2023)

1186. Beta is Better: Impact of a Multifaceted Stewardship Initiative on the Sequential Timing of Beta-Lactam Administration
por: Deri, Connor R, et al.
Publicado: (2023)

127. Evaluation of Real-Time Verigene Blood Culture Alerts on Time to Optimal Antibiotic Therapy
por: Adams, David T, et al.
Publicado: (2023)

1112. Vancomycin Nephrotoxicity Relative to Alternative Antibiotic Treatments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ibragimova, Nayle, et al.
Publicado: (2021)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Beta-lactam hypersensitivity: not always what it seems
por: Andrade, Djanira, et al.
Publicado: (2015)

1181. Evaluation of the Safety of a Beta-Lactam Allergy Protocol
por: Sakowski, Alexandra K, et al.
Publicado: (2023)

1267. Implementation and Outcomes of Beta-lactam Allergy Management Protocol at a Comprehensive Cancer Center
por: Khalak, Sohanabanu, et al.
Publicado: (2023)

Initial Fluid Resuscitation Following Adjusted Body Weight Dosing in Sepsis and Septic Shock
por: Antal, Oana, et al.
Publicado: (2019)

936. Antimicrobial Stewardship Assessments in De-labeling Beta-lactam Allergies
por: Fahmy, Nicole, et al.
Publicado: (2022)

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

2545: Integration of HMIS and UI Health Cerner Clinical System to enable data sharing about homeless individuals
por: Bahroos, Neil, et al.
Publicado: (2018)

Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020)

608. Evaluation of Safety of High-Dose Beta-Lactam Antibiotics in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
por: Varona, Jerald, et al.
Publicado: (2022)

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

Preload assessment in septic shock
por: Donati, A, et al.
Publicado: (2000)

Hypocalcemia in children with septic shock
por: Buysse, CMP, et al.
Publicado: (2001)

Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock
por: Russell, James A., et al.
Publicado: (2019)

261. Adaptive Immunosuppression in Children with Septic Shock
por: Cruz Vidal, Diego A, et al.
Publicado: (2023)

Microcirculatory blood flow in the gastrointestinal tract during early septic shock
por: Hiltebrand, L, et al.
Publicado: (1998)

1464. β-lactam versus Non-β-lactam Alternatives for Colorectal Surgical Prophylaxis: Does Recommended Dosing and Timing Matter?
por: Collins, Curtis D, et al.
Publicado: (2023)

Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022)

189. Outcomes of High-dose Oral Beta-lactam Step-down Therapy Compared to Alternative Oral Therapy for Bacteremic Urinary Tract Infections
por: Geyer, Abigail, et al.
Publicado: (2023)

30. Implementation of the PEN-FAST Penicillin Allergy Screening Tool in the Emergency Department During Medication Reconciliation
por: Kaur, Satwinder Sony, et al.
Publicado: (2021)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Myocardial cell injury in septic shock
por: Rodrigues, MG, et al.
Publicado: (2003)

METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

A Rare Case of Septic Shock Secondary to Emphysematous Hepatitis
por: Nada, Khaled M., et al.
Publicado: (2017)

141. Evaluating Cefepime And Alternative Beta-lactams For The Treatment Of Serratia marcescens Blood Stream Infections
por: Vicente-Lopez, Natcha, et al.
Publicado: (2022)

193. Standard of Care versus Alternative Beta-lactams for Treatment of Infections due to Serratia marcescens
por: Green, Sarah B, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q9hjelgqm18gmfsnangcvf058k